Kexing Biopharm Co Ltd
SSE:688136
Kexing Biopharm Co Ltd
SSE:688136
Price:
30.84
CNY
-1.56%
Market Closed
Market Cap:
¥6.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kexing Biopharm Co Ltd
SSE:688136
|
CN |
|
C
|
Cho Lon Real Estate JSC
VN:RCL
|
VN |
|
Semen Indonesia (Persero) Tbk PT
OTC:PSGTY
|
ID |
|
D
|
Dai Nippon Printing Co Ltd
XBER:DNP
|
JP |
|
S
|
South Logistics JSC
VN:STG
|
VN |
|
Manufactured Housing Properties Inc
OTC:MHPC
|
US |
|
Bresler and Reiner Inc
OTC:BRER
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
OTC:CHGCY
|
JP |
|
LibertyStream Infrastructure Partners Inc
F:3ZM
|
CA |
|
S
|
South32 Ltd
LSE:S32
|
AU |
|
Nostra Terra Oil and Gas Company PLC
LSE:NTOG
|
UK |
|
S
|
Shandong Molong Petroleum Machinery Co Ltd
OTC:SHANF
|
CN |
|
M
|
MindBio Therapeutics Corp
CNSX:MBIO
|
CA |
|
C
|
CHTC Fong's International Co Ltd
HKEX:641
|
HK |
|
S
|
SBM Offshore NV
VSE:SBMO
|
NL |
|
J
|
JEP Holdings Ltd
SGX:1J4
|
SG |
|
Otto Energy Ltd
ASX:OEL
|
AU |
Cash Flow Statement
Cash Flow Statement
Kexing Biopharm Co Ltd
Kexing Biopharm Co Ltd
Currency: CNY
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
6
|
0
|
0
|
|
| Cash Taxes Paid |
(135)
|
(88)
|
(83)
|
(79)
|
(61)
|
(48)
|
(42)
|
(39)
|
(24)
|
(36)
|
(35)
|
(43)
|
(49)
|
(46)
|
(50)
|
(42)
|
(60)
|
(64)
|
(61)
|
(69)
|
(53)
|
|
| Change in Working Capital |
(1 137)
|
(811)
|
(791)
|
(811)
|
(855)
|
(877)
|
(954)
|
(974)
|
(1 052)
|
(1 112)
|
(1 090)
|
(1 143)
|
(1 115)
|
(1 023)
|
(1 068)
|
(1 006)
|
(966)
|
(918)
|
(790)
|
(756)
|
(711)
|
|
| Cash from Operating Activities |
55
N/A
|
98
+78%
|
106
+8%
|
126
+19%
|
135
+7%
|
108
-20%
|
94
-13%
|
48
-49%
|
(19)
N/A
|
(81)
-321%
|
(86)
-6%
|
(122)
-42%
|
(139)
-14%
|
(55)
+60%
|
(87)
-57%
|
(47)
+46%
|
(34)
+27%
|
41
N/A
|
107
+163%
|
138
+30%
|
170
+23%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(125)
|
(126)
|
(189)
|
(198)
|
(216)
|
(306)
|
(372)
|
(433)
|
(530)
|
(473)
|
(399)
|
(334)
|
(273)
|
(254)
|
(191)
|
(192)
|
(111)
|
(85)
|
(94)
|
(65)
|
(73)
|
|
| Other Items |
1
|
3
|
(12)
|
(616)
|
(283)
|
(371)
|
(121)
|
457
|
(72)
|
89
|
18
|
(216)
|
90
|
(90)
|
35
|
108
|
114
|
122
|
(10)
|
74
|
(111)
|
|
| Cash from Investing Activities |
(124)
N/A
|
(123)
+1%
|
(201)
-63%
|
(814)
-306%
|
(499)
+39%
|
(677)
-36%
|
(492)
+27%
|
24
N/A
|
(602)
N/A
|
(384)
+36%
|
(381)
+1%
|
(550)
-44%
|
(183)
+67%
|
(344)
-88%
|
(156)
+55%
|
(84)
+46%
|
2
N/A
|
38
+1 432%
|
(104)
N/A
|
10
N/A
|
(184)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
13
|
0
|
0
|
0
|
7
|
0
|
26
|
|
| Net Issuance of Debt |
174
|
106
|
114
|
(14)
|
(14)
|
147
|
241
|
511
|
613
|
502
|
443
|
340
|
280
|
152
|
67
|
60
|
19
|
(15)
|
68
|
52
|
108
|
|
| Cash Paid for Dividends |
0
|
0
|
(11)
|
(13)
|
(31)
|
(35)
|
(28)
|
(31)
|
(43)
|
(46)
|
(54)
|
(59)
|
(43)
|
(47)
|
(45)
|
(46)
|
(43)
|
(44)
|
(44)
|
(43)
|
(58)
|
|
| Other |
9
|
(14)
|
933
|
926
|
940
|
954
|
(26)
|
(11)
|
(13)
|
(16)
|
(18)
|
(18)
|
(14)
|
(14)
|
(18)
|
(35)
|
(52)
|
(50)
|
(42)
|
(22)
|
(57)
|
|
| Cash from Financing Activities |
183
N/A
|
92
-50%
|
1 036
+1 028%
|
898
-13%
|
895
0%
|
1 067
+19%
|
187
-82%
|
469
+151%
|
558
+19%
|
439
-21%
|
371
-15%
|
263
-29%
|
231
-12%
|
98
-57%
|
16
-83%
|
(9)
N/A
|
(72)
-721%
|
(104)
-45%
|
(11)
+89%
|
(7)
+37%
|
20
N/A
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
(2)
|
(3)
|
(3)
|
(4)
|
(2)
|
(2)
|
(3)
|
2
|
5
|
5
|
5
|
5
|
2
|
3
|
4
|
1
|
1
|
1
|
1
|
1
|
|
| Net Change in Cash |
115
N/A
|
65
-43%
|
938
+1 340%
|
207
-78%
|
527
+154%
|
496
-6%
|
(214)
N/A
|
537
N/A
|
(61)
N/A
|
(20)
+67%
|
(91)
-344%
|
(404)
-344%
|
(87)
+79%
|
(299)
-245%
|
(224)
+25%
|
(135)
+40%
|
(102)
+25%
|
(25)
+76%
|
(7)
+72%
|
142
N/A
|
8
-94%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(70)
N/A
|
(28)
+61%
|
(83)
-202%
|
(71)
+14%
|
(80)
-13%
|
(198)
-146%
|
(278)
-40%
|
(385)
-39%
|
(549)
-42%
|
(554)
-1%
|
(485)
+12%
|
(456)
+6%
|
(413)
+10%
|
(310)
+25%
|
(278)
+10%
|
(238)
+14%
|
(145)
+39%
|
(44)
+70%
|
13
N/A
|
74
+482%
|
97
+32%
|
|
Switch to:
Switch to:
See Also
Discover More
